Penn State CRC
University Park, Pennsylvania, 16803, United States
NCT Number: NCT02557334
The purpose of this study is to evaluate the effects of freeze dried strawberry powder on LDL cholesterol, central and peripheral blood pressure, indices of arterial stiffness, and other lipid and lipoprotein concentrations. The investigators hypothesize that the bioactive compounds in freeze dried strawberry powder may elicit beneficial effects on LDL cholesterol, as well as blood pressure and arterial health.
Looking for future studies?
Notify Me35 year–65 year
All sexes
Interventional
Not applicable
University Park, Pennsylvania, 16803, United States
The proposed study design is a 3-period randomized crossover dose-response study to evaluate the effect of freeze dried strawberry powder supplementation on LDL-C and vascular health. Research participants will be overweight or obese (BMI 25-39 kg/m^2) but otherwise healthy adults with moderately elevated LDL-C (>116 mg/dL or >3.0mmol/L), blood pressure <160/100 mmHg, total cholesterol below 273 mg/dL for men and below 284 mg/dL for women, and triglycerides below 350 mg/dL. Subjects will be randomly assigned to three supplementation periods: 1) low dose freeze dried strawberry powder (13 g/d); 2) high dose freeze dried strawberry powder (40 g/d); and 3) a placebo powder. Each powder will be provided for 4-6 weeks, separated by a 2-week washout period between treatment periods. Baseline and endpoint testing will include blood collection and vascular testing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
40 g composed of 13 g freeze dried strawberry powder + 27 g placebo powder
40 g freeze dried strawberry powder
40 g color and taste matched placebo powder
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
LDL-C values calculated using the Friedewald equation
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Aortic (central) blood pressure measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Peripheral blood pressure measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Augmentation index measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Pulse wave velocity measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Total cholesterol values determined by enzymatic procedures
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Triglyceride values determined using enzymatic procedures
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
HDL-C will be estimated according to the modified heparin-manganese procedure
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Plasma concentrations of oxLDL will be measured using ELISA kits
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
MDA will be measured using the thiobarbituric acid reactive substances (TBARS) assay
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
hs-CRP will be measured by latex-enhanced immunonephelometry
Penn State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07738250
Cancer Survivorship, Cardiovascular Disease
View Trial DetailsNCT01778569
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02840448
Aortic Stenosis, Supravalvular, Aortic Valve Disease
Bethesda, Maryland, United States
View Trial DetailsNCT01934660
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial Details